港交所总裁陈翊庭：A+H股占新股融资七成、海外投资者热情高，新股融资额重回全球交易所榜首

Core Insights - Hong Kong Stock Exchange (HKEX) has experienced a strong market performance in the first half of the year, with record trading volumes in spot and derivative products, as well as in the Stock Connect program with mainland China [1][3] - New equity financing in Hong Kong reached HKD 134.5 billion by the end of August, marking a nearly sixfold increase compared to the same period in 2024, with A+H listings accounting for 70% of total financing [3] - The interest from international investors in subscribing to new shares, particularly in technology companies, indicates a growing confidence in China's technological innovation [3] Company and Industry Developments - The total amount of refinancing for companies listed in Hong Kong reached HKD 358 billion by the end of August, more than double the new equity fundraising during the same period, with nearly 40% of this coming from technology firms [3] - The Hong Kong Stock Exchange has launched a "Tech Company Fast Track" to provide one-stop listing consultation services for specialized technology and biotech companies, enhancing communication efficiency and transparency [3][5] - As of the end of August, there are 24 biotech companies and 12 specialized tech companies with listing applications in process, showcasing Hong Kong's strong appeal and inclusivity for innovative enterprises [4] Regulatory Changes - HKEX has implemented reforms to optimize the new share pricing mechanism and public market requirements, which include relaxing public shareholding ratio requirements and increasing institutional investor participation in new share pricing [5]